The CONSORT group is pleased to announce the development of a new extension for reporting quality of life data from clinical trials. Improved reporting of quality of life in clinical trials will enable robust evidence to inform patient choice, aid clinical decision making, and inform health policy.
The extension is a collaboration between the International Society for Quality of Life Research (ISOQOL), the CONSORT Executive, the Midland and COnDuCT Medical Research Council Hubs for Trials Methodology Research (MRC MHTMR), journal editors, policy makers and patient representatives.
A Delphi exercise is currently in progress and the Consensus Meeting will be held in London, UK in January 2012. Please watch out for further updates.
For further information please contact email@example.com.